{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:39:10Z","timestamp":1787243950778,"version":"build-2736575974"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Medtronic and Xyken"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,5]]},"DOI":"10.1093\/cid\/ciy620","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T07:40:35Z","timestamp":1533109235000},"page":"1024-1030","source":"Crossref","is-referenced-by-count":13,"title":["The Utility of Screening for Coccidioidomycosis in Recipients of Inhibitors of Tumor Necrosis Factor \u03b1"],"prefix":"10.1093","volume":"68","author":[{"given":"Kristal","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Loma Linda University, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Deval","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Vyas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Moran","sequence":"additional","affiliation":[{"name":"School of Graduate Medical Education, College of Medicine and Science, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S","family":"Cha","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester E","family":"Mertz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana F","family":"Pasha","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Yiannias","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis E","family":"Blair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"key\n\t\t\t\t2019030423555786300_CIT0001","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0002","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coph.2010.01.005","article-title":"Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases","volume":"10","author":"Taylor","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0003","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.autrev.2009.08.006","article-title":"Incidence and nature of infectious disease in patients treated with anti-TNF agents","volume":"9","author":"Raychaudhuri","year":"2009","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0004","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.20454","article-title":"Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists","volume":"50","author":"Bergstrom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.smj.0000242797.49218.44","article-title":"Coccidioidomycosis pneumonia in a nonendemic area associated with infliximab","volume":"100","author":"Dweik","year":"2007","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1752-1947-1-79","article-title":"Fatal miliary coccidioidomycosis in a patient receiving infliximab therapy: a case report","volume":"1","author":"Rogan","year":"2007","journal-title":"J Med Case Rep"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0007","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/acr.21784","article-title":"Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs","volume":"64","author":"Taroumian","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1406.027","article-title":"Coccidioidomycosis in rheumatology patients: incidence and potential risk factors","volume":"1111","author":"Mertz","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0009","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0011","doi-asserted-by":"crossref","first-page":"487","DOI":"10.12659\/MSM.890331","article-title":"A guide to prepare patients with inflammatory bowel diseases for anti-TNF-\u03b1 therapy","volume":"20","author":"Chebli","year":"2014","journal-title":"Med Sci Monit"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0012","first-page":"C4480","article-title":"Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment","volume":"59","author":"Nordgaard-Lassen","year":"2012","journal-title":"Dan Med J"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0013","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ibd.21824","article-title":"Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy","volume":"18","author":"Vaughn","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0014","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/ajt.12144","article-title":"The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients","volume":"13","author":"Mendoza","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11046-006-0062-5","article-title":"Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts","volume":"162","author":"Blair","year":"2006","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0016","article-title":"Numbers needed to treat","author":"Harding"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0017","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/323463","article-title":"Coccidioidomycosis in solid organ transplantation","volume":"33","author":"Blair","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0018","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-6143.2005.01169.x","article-title":"Coccidioidomycosis after renal transplantation in an endemic area","volume":"6","author":"Braddy","year":"2006","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1399-3062.2003.00005.x","article-title":"Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area","volume":"5","author":"Blair","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t2019030423555786300_CIT0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CVI.00531-12","article-title":"Clinical specificity of the enzyme immunoassay test for coccidioidomycosis varies according to the reason for its performance","volume":"20","author":"Blair","year":"2013","journal-title":"Clin Vaccine Immunol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/6\/1024\/28009279\/ciy620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T23:56:09Z","timestamp":1551743769000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/6\/1024\/5063825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,8,2]]},"published-print":{"date-parts":[[2019,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy620","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2018,8,2]]}}}